Primecap Management
NRIX icon

Primecap Management’s Nurix Therapeutics NRIX Stock Holding History

Primecap Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-170,000
Closed -$1.57M – 332
2025
Q3 		$1.57M Sell
170,000
-40,000
-19% -$415K ﹤0.01% 309
2025
Q2 		$2.39M Sell
210,000
-22,000
-9% -$238K ﹤0.01% 304
2025
Q1 		$2.76M Hold
232,000
– – ﹤0.01% 297
2024
Q4 		$4.37M Sell
232,000
-58,000
-20% -$1.33M ﹤0.01% 281
2024
Q3 		$6.52M Hold
290,000
– – ﹤0.01% 277
2024
Q2 		$6.05M Buy
290,000
+11,000
+4% +$171K ﹤0.01% 274
2024
Q1 		$4.1M Buy
+279,000
New +$3M ﹤0.01% 289

Other funds holding NRIX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return